CTNM vs IRM · $429.6M cap vs P/E 136, rev $3.97B
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) versus Iron Mountain Incorporated (IRM) — a side-by-side from cached financials, not a winner call.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company listed on US.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
Latest reported CTNM revenue for 2024-09-30 was $0. Net income was -$27.7M. CTNM currently screens at market cap $429.6M.
Latest reported IRM revenue for 2026-06-30 was $3.97B. Net income was $255.1M. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
CTNM currently screens at market cap $429.6M. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
Not investment advice. Open the CTNM and IRM stock pages for the full models.
Not investment advice.